These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6349538)

  • 1. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
    Taguchi T
    Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
    Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
    Kosaka A; Wani T; Hattori Y; Yamashita A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of phase III study of lentinan].
    Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
    Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
    Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
    Yagi M; Watanabe S; Yoshino S; Hazama S; Suga T; Nakazawa S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):457-62. PubMed ID: 20332683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
    Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
    Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
    Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
    Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
    Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
    Chihara G
    Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
    Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
    J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
    Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
    Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
    Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
    Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
    Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)].
    Taguchi T; Kosaki G; Onodera T; Endo M; Nakagawara G; Sano K; Kaibara N; Kakegawa T; Nakano S; Kurihara M
    Gan To Kagaku Ryoho; 1995 May; 22(6):753-64. PubMed ID: 7755383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.